An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease

References

• VakilNvan ZantenSVKahrilasPDentJJonesRThe Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensusAm J Gastroenterol200610119001920 quiz194316928254
   PubMed Web of Science ®Google Scholar
• ScholtenTLong-term management of gastroesophageal reflux disease with pantoprazoleTher Clin Risk Manag2007323124318360632
   PubMedGoogle Scholar
• HollenzMStolteMLabenzJPrevalence of gastro-oesophageal reflux disease in general practiceDtsch Med Wochenschr20021271007101211997867
   PubMed Web of Science ®Google Scholar
• RevickiDAWoodMMatonPNSorensenSThe impact of gastroesophageal reflux disease on health-related quality of lifeAm J Med19981042522589552088
   PubMed Web of Science ®Google Scholar
• EnckPDuboisDMarquisPQuality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST)Scand J Gastroenterol Suppl1999231485410565623
   PubMedGoogle Scholar
• DimenasEGliseHHallerbackBHernqvistHSvedlundJWiklundIQuality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?Scand J Gastroenterol1993286816878210982
   PubMed Web of Science ®Google Scholar
• DeVaultKRCastellDOUpdated guidelines for the diagnosis and treatment of gastroesophageal reflux diseaseAm J Gastroenterol200510019020015654800
   PubMed Web of Science ®Google Scholar
• FischerJGanellinCRAnalogue Based-Drug Discovery1st EditionWiley-VCH Verlag GmBh&Co.2006115136
   Google Scholar
• PoolePPantoprazoleAm J Health Syst Pharm200158999100811402494
   PubMed Web of Science ®Google Scholar
• CheerSMPrakashAFauldsDLambHMPantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disordersDrugs20036310113312487624
   PubMed Web of Science ®Google Scholar
• DevaultKRPantoprazole: a proton pump inhibitor with oral and intravenous formulationsExpert Rev Gastroenterol Hepatol2007119720519072410
   PubMedGoogle Scholar
• ShiSKlotzUProton pump inhibitors: an update of their clinical use and pharmacokineticsEur J Clin Pharmacol20086493595118679668
   PubMed Web of Science ®Google Scholar
• SachsGProton pump inhibitors and acid-related diseasesPharmacotheraphy1997172237
   PubMed Web of Science ®Google Scholar
• RichterJEFragaPMackMSabesinSMBochenekWPrevention of erosive oesophagitis relapse with pantoprazoleAliment Pharmacol Ther20042056757515339328
   PubMed Web of Science ®Google Scholar
• CalabreseCFabbriADiFeboGLong-term management of GERD in the elderly with pantoprazoleClin Interv Aging20072859218044079
   PubMed Web of Science ®Google Scholar
• AvnerDLClinical experience with pantoprazole in gastroesophageal reflux diseaseClin Ther20002211691185 discussion1149115011110229
   PubMed Web of Science ®Google Scholar
• ShinJMSachsGRestoration of acid secretion following treatment with proton pump inhibitorsGastroenterology20021231588159712404233
   PubMed Web of Science ®Google Scholar
• HartmannMTheissUHuberRTwenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazoleAliment Pharmacol Ther1996103593668791964
   PubMed Web of Science ®Google Scholar
• Van RensburgCJHoniballPJVan ZylJHSafety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis – a 2-year follow-upAliment Pharmacol Ther1999131023102810468676
   PubMed Web of Science ®Google Scholar
• TanakaMOhkuboTOtaniKStereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoinClin Pharmacol Ther20016910811311240974
   PubMed Web of Science ®Google Scholar
• KahrilasPJShaheenNJVaeziMFAmerican Gastroenterological Association Medical Position Satement on the management of gastroesophageal refluz diseaseGastroenterology20081351383139118789939
   PubMed Web of Science ®Google Scholar
• GalloSDibildoxMMoguelAClinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study GroupRev Gastroenterol Mex199863111610068743
   PubMedGoogle Scholar
• DammannHVon KleistEfficacy and tolerability of pantoprazole versus ranitidine and famotidine in patients with gastro-oesopghageal reflux disease: multicentre, open, randomised, control studiesInternational Clinical Practice Series1997152329
   Google Scholar
• KovacsTOWilcoxCMDeVaultKMiskaDBochenekWComparison of the efficacy of panctoprazole vs nizatidine in the treatment of erosive oesophagtitis: a randomized active-controlled, double0blind studyAliment Pharmacol Ther2002162043205212452936
   PubMed Web of Science ®Google Scholar
• RichterJEBochenekWOral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study GroupAm J Gastroenterology20009530713080
   PubMed Web of Science ®Google Scholar
• MeneghelliUGBoaventuraSMoraes-FilhoJPEfficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rateDis Esophagus200215505612060043
   PubMed Web of Science ®Google Scholar
• ArmstrongDParePPericakDPyzykMSymptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux diseaseAm J Gastroenterol2001962849285711695354
   PubMed Web of Science ®Google Scholar
• MetzDCBochenekWJPantoprazole maintenance therapy prevents relapse of erosive oesophagitisAliment Pharmacol Ther20031715516412492745
   PubMed Web of Science ®Google Scholar
• SimonBMullerPPascuOGatzGSanderPHuberRMascherHIntra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro-oesophageal reflux diseaseEur J Gastroenterol Hepatol20031579179912811310
   PubMed Web of Science ®Google Scholar
• MulderCJWesterveldBDSmitJMA double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trialEur J Gastroenterol Hepatol20021464965612072599
   PubMed Web of Science ®Google Scholar
• GlatzelDAbdel-QaderMGatzGPfaffenbergerBPantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapseDigestion20067414515417230024
   PubMed Web of Science ®Google Scholar
• KoernerTComparable efficacy of pantoprazole 40 mg vs omeprazole MUPS 40 mg in patients with GERD II/IIIGut200251A166
   Google Scholar
• GohKLBenamouzigRSanderPSchwanTEfficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial–the EMANCIPATE studyEur J Gastroenterol Hepatol20071920521117301646
   PubMed Web of Science ®Google Scholar
• LaurtisenComparable efficacy of pantoprazole and omeprazole to prevent relapse in patients with GERDGut200047Suppl III39 (A60).
   Google Scholar
• HoltmannGInternational validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux diseaseAliment Pharmacol Ther20092961562519183145
   PubMed Web of Science ®Google Scholar
• ScholtenTPantoprazole 40 mg relieves primary reflux symptoms more rapidly than omeprazole MUPS 20 mg in patients with severe GERD symptomatologyGastroenterology2000118A1303
   Web of Science ®Google Scholar
• EhrlichALueckerPWWiedemannASanderPHuberRMascherHComparison of the pharmacodynamics and pharmacokinetics of pantoprazole (40 mg) as compared to omeprazole MUPS (20 mg) after repeated oral dose administrationMethods Find Exp Clin Pharmacol199921475110222447
   PubMedGoogle Scholar
• ThomsonAImpact of PPIs on patient focused symptomatology in GERDTher Clin Risk Manag200841185120019337426
   PubMedGoogle Scholar
• OrrWCNight-time gastro-oesophageal reflux disease: prevalence, hazards, and managementEur J Gastroenterol Hepatol20051711312015647651
   PubMed Web of Science ®Google Scholar
• ParePArmstrongDPericakDPyzykMPantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidineJ Clin Gastroenterol20033713213812869883
   PubMed Web of Science ®Google Scholar
• BardhanKDStanghelliniVArmstrongDBerghoferPGatzGMonnikesHInternational validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux diseaseDigestion200775Suppl 1485417489032
   PubMed Web of Science ®Google Scholar
• ScholtenTTeutschIBohuschkeMGatzGPantoprazole on-demand effectively treats symptoms in patients with gastro-oesophageal reflux diseaseClin Drug Investig200727287296
   PubMed Web of Science ®Google Scholar
• KaspariSKupcinskasLHeinzeHBerghoferPPantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux diseaseEur J Gastroenterol Hepatol20051793594116093871
   PubMed Web of Science ®Google Scholar
• ScholtenTDekkersCPSchutzeKKornerTBohuschkeMGatzGOn-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trialDigestion200572768516113546
   PubMed Web of Science ®Google Scholar
• MetzDCPrathaVMartinPOral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux diseaseAm J Gastroenterol20009562663310710049
   PubMed Web of Science ®Google Scholar
• HoganDPrathaVRiffDOral pantoprazole in the form of granules or tablets are pharmacodynamically equivalent in suppressing acid output in patients with gastro-oesophageal reflux disease and a history of erosive oesophagitisAliment Pharmacol Ther20072624925617593070
   PubMed Web of Science ®Google Scholar
• FittonAWisemanLPantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disordersDrugs1996514604828882382
   PubMed Web of Science ®Google Scholar
• Martin de ArgilaCSafety of potent gastric acid inhibitionDrugs200565Suppl 19710416335863
   PubMed Web of Science ®Google Scholar
• MooreISayerJANayarAAhmedSTapsonJSPantoprazole-induced acute interstitial nephritisJ Nephrol20041758058115372423
   PubMed Web of Science ®Google Scholar
• RaATobeSWAcute interstitial nephritis due to pantoprazoleAnn Pharmacother200438414514742791
   PubMed Web of Science ®Google Scholar
• WatsonTDStarkJEVestaKSPantoprazole-induced thrombocytopeniaAnn Pharmacother20064075876116569810
   PubMed Web of Science ®Google Scholar
• TargownikLELixLMMetgeCJPriorHJLeungSLeslieWDUse of proton pump inhibitors and risk of osteoporosis-related fracturesCMAJ200817931932618695179
   PubMed Web of Science ®Google Scholar
• PrathaVHoganDLLynnRBFieldBMetzDCIntravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trialDig Dis Sci2006511595160116927137
   PubMed Web of Science ®Google Scholar
• DupasJLHouckePSamoyeauRPantoprazole versus lansoprazole in French patients with reflux esophagitisGastroenterol Clin Biol20012524525011395670
   PubMedGoogle Scholar
• CorinaldesiRValentiniMBelaicheJColinRGeldofHMaierCPantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre studyAliment Pharmacol Ther199596676718824655
   PubMed Web of Science ®Google Scholar
• ScholtenTHahnEGBosseckertHClinical tolerability of pantoprazole compared with ranitidine and famotidineInternational Clinicial Practice Series1997153136
   Google Scholar
• Siller-MatulaJMSpielAOLangIMKreinerGChristGJilmaBEffects of pantoprazole and esomeprazole on platelet inhibition by clopidogrelAm Heart J2009157148e1e519081411
   PubMed Web of Science ®Google Scholar
• CaiQBarrieMOlejemeHRoserbergMA Pilot Study of Efficacy and Safety of Continuous Intravenous Infusion of Pantoprazole in the Treatment of Severe Erosive EsophagitisDig Dis Sci2008531500150517985242
   PubMed Web of Science ®Google Scholar
• TsouVMBakerRBookLMulticenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD)Clin Pediatr (Phila)20064574174916968960
   PubMed Web of Science ®Google Scholar
• ToliaVBishopPRTsouVMGremseDSofferEFComerGMMulticenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5–11 years) with symptomatic gastroesophageal reflux diseaseJ Pediatr Gastroenterol Nutr20064238439116641576
   PubMed Web of Science ®Google Scholar